Best St. Joseph County Grants for Nonprofits in Michigan

The NCI Continuing Umbrella of Research Experiences (CURE) Non-Mentored Research Scientist Career Development Award (K22) aims to support postdoctoral fellows from underrepresented backgrounds in transitioning to tenure-track positions. This award provides essential funding for salary and research support for three years, enabling candidates to establish independent biomedical careers. Key deadlines for applications range from February 2025 to October 2027, ensuring ample opportunity for eligible researchers to secure funding for their career development.

The NCI Continuing Umbrella of Research Experiences (CURE) Non-Mentored Research Scientist Career Development Award (K22) supports early-career independent researchers to transition from postdoctoral positions to assistant professor roles. This award aims to enhance diversity in the biomedical workforce, offering funding opportunities for innovative research projects. Key application deadlines span from February 2025 to October 2027. The program is funded by the US Department of Health & Human Services, specifically the National Institutes of Health (NIH).

The NIH Career Transition Award (K22) supports exceptional basic and clinical investigators in developing independent research skills through a two-phase program: an intramural appointment at NIH followed by support at an extramural institution. This award specifically aids NINDS intramural neurologist and neurosurgeon scientists in transitioning to independent academic faculty roles, fostering the engagement of clinician-scientists in both funded scientific research and clinical practices.

The NIH Career Transition Award (K22) aims to support outstanding clinician-scientists in developing independent research skills. This grant facilitates a two-phase program, starting with an intramural appointment at the NIH followed by support at an extramural institution. Designed for NINDS intramural neurologist- and neurosurgeon-scientists, it helps them transition to independent academic faculty roles, enabling them to engage in funded scientific research alongside clinical activities.

The NCI CURE Mentored Clinical Scientist Research Career Development Award (K08) aims to support individuals with clinical doctoral degrees in developing research careers that address national health-related needs. This program focuses on enhancing the research capabilities of underrepresented clinical scientists in cancer research, including health disparities. Awardees receive protected time for supervised research training, preparing them to compete for future research project grants. Key deadlines for applications span from February 2025 to October 2027.

The NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required) grant invites applications for mid-phase clinical trials focusing on natural products such as botanicals and dietary supplements. It aims to advance scientific knowledge by determining optimal dosing and patient responses. Applicants must provide preliminary data demonstrating bioavailability and measurable impacts on target engagement. This initiative will not support efficacy trials for cancer treatments and encourages early contact with NCCIH scientific contacts.

The NCCIH Natural Product Early Phase Clinical Trial Award supports innovative clinical trials of natural products, such as botanicals and dietary supplements, with a strong scientific basis. Applications are encouraged to explore optimal delivery methods and combinations with other treatments. Funding is available for up to three years to assess the impact on target engagement and clinical outcomes, aiming to translate basic science findings into practical clinical applications.

The NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33) invites research proposals for early phase clinical trials of natural products, including botanicals and dietary supplements, emphasizing scientific validity for further testing. Applicants may receive up to three years of funding for pharmacokinetics and bioavailability studies, with potential for an additional three years to evaluate clinical outcomes. This initiative aims to optimize natural product delivery through innovative study designs.

U.S. Writers Aid Initiative

PEN America is an organization of writers and their allies, and that solidarity is never more important than when members of our literary community face crises. PEN America’s U.S. Writers Aid Initiative, part of the PEN America Writers Emergency Fund, offers grants for writers in the United States facing acute financial need following an emergency situation.

The U.S. Writers Aid Initiative is intended to assist fiction and nonfiction authors, poets, playwrights, translators, and journalists in addressing short-term financial emergencies. To be eligible, applicants must be professional writers based in the United States, and be able to demonstrate that this one-time grant will be meaningful in helping address a short-term emergency situation. The fund is limited, and not every application can be supported.

Grant decisions are made on a quarterly basis by a volunteer committee of literary peers in consultation with PEN America staff, using the following guidelines to evaluate professional credentials:

• Publication of one or more books. (Writers who are only self-published or published by a press that charges for publication are not eligible.)
• Multiple essays, short stories, or poems appearing in literary anthologies or literary journals (either online or in print) in the last two years.
• A full-length play, performed in a theater by a professional theater company. Productions in academic settings qualify if the author is not a student at the time of the production.
• Employment as a full-time professional journalist, columnist, or critic, or a record of consistent publication on a freelance basis in a range of outlets during the last two years.
• Contracted forthcoming books, essays, short stories, poems, or articles for which the name of the publisher can be provided.
• Other qualifications that support the applicant’s professional identity as a writer.

The AGA-Bern Schwartz Family Fund Research Scholar Award in Pancreatic Cancer provides $100,000 annually for three years to early-career faculty in digestive disease research. This award aims to support independent careers in pancreatic cancer research by protecting a significant portion of the recipient's time for research activities. Eligible applicants must hold an MD, PhD, or equivalent and work at a North American institution, with AGA membership required. Strong encouragement is given to underrepresented groups.

The AGA-Bern Schwartz Family Fund Research Scholar Award in Pancreatic Cancer provides $100,000 annually for three years to early-career faculty focused on independent research in pancreatic cancer. This award aims to protect at least 50% of the recipient's time for research activities. Eligible applicants must hold an MD or PhD and be classified as early-career. The award encourages physician-scientists and underrepresented groups in biomedical research to apply, supporting innovative research that can lead to significant advancements in understanding pancreatic cancer.

The AGA-Gastric Cancer Foundation Ben Feinstein Memorial Research Scholar Award provides $100,000 annually for three years to early-career faculty dedicated to gastric cancer research. Eligible candidates must have an MD, PhD, or equivalent and a full-time faculty position in North America. The award supports research in various areas related to gastric cancer, ensuring a minimum of 50% time commitment to the project, thus fostering independent careers in digestive diseases.

The American Diabetes Association's Postdoctoral Fellowship Awards aim to foster emerging leaders in diabetes research. With a focus on innovative research, these fellowships provide up to three years of funding, including a stipend and allowances. Eligible applicants must hold a recent advanced degree and conduct research at U.S. affiliated institutions. This initiative not only supports career development but also contributes significantly to the mission of preventing and curing diabetes.

The Zuckerman Postdoctoral Scholars Program fosters collaboration between leading scientific institutions in the U.S. and Israel by attracting top postdoctoral researchers. With a focus on STEM leadership, this program offers a unique two-year scholarship, allowing scholars to conduct research at participating Israeli universities and North American institutions. The initiative aims to strengthen academic ties, enhance research capabilities, and support the return of talented Israeli scholars to their home institutions, ultimately enriching the global scientific community.

The Tides Stronger Together Fund, under the Tides Foundation, provides essential support grants to fiscally sponsored partners focused on historically underserved communities. By building organizational capacity and leadership, the fund empowers community changemakers to address inequities and enhance sustainability. With a pooled funding model, it directly responds to the needs of over 120 partners, ensuring resources are effectively allocated where they are most impactful, ultimately fostering long-term community resilience.

The Lisa and Douglas Goldman Fund, established in 1992, supports charitable organizations that enhance society, focusing on democracy and civil liberties. The fund prioritizes projects that ensure equal citizen participation in the democratic process and protect civil liberties, especially those implemented nationally or across multiple states. It operates by invitation only and emphasizes flexible, informed grantmaking to qualified projects that align with its mission and values.

The HEAL Initiative aims to identify new druggable targets for pain within the understudied proteome. This funding opportunity invites applications for pilot projects that generate preliminary data and tools for exploring these targets. The initiative seeks to enhance research on understudied proteins related to pain management, providing essential funding for biochemical and biological work. This NOFO is part of the NIH's broader effort to develop novel medications that address various aspects of opioid addiction and its consequences.

The Limited Competition Small Grant Program under the NCATS CTSA aims to enhance the research capabilities of scholars transitioning to independent academic translational scientists. This program supports diverse clinical and translational science projects, including pilot studies and methodology development. The R03 grants are designed for short-term projects with limited resources that generate preliminary data for future R01 applications, thereby fostering innovation and advancing health research.

The Limited Competition: Clinical and Translational Science Award (CTSA) Program's Collaborative and Innovative Acceleration Award aims to enhance translational research by fostering collaboration in developing and implementing innovative solutions. This funding opportunity invites applications focused on new approaches and technologies that will improve research impact across various diseases and expedite treatment availability. Eligible applicants include organizations with active CTSA hub prime or partnering awards.

The Outdoor Recreation Legacy Partnership Program (ORLP) is a competitive grant initiative by the National Park Service, aimed at enhancing parks and recreational opportunities in urban, underserved communities. This program supports the acquisition, development, and renovation of outdoor recreation areas through federal funding, addressing the needs of community organizations, local governments, and recognized tribes. Applications are accepted twice a year, before June 1 and November 1.

The Environmental Justice Thriving Communities Grantmaking Program, led by The Minneapolis Foundation, supports community-based nonprofits in the Great Lakes region. With a focus on underserved communities, grants will total $40 million over three years, aiming to enhance environmental health, education, and resilience. The program prioritizes applications from federally recognized tribes and organizations with limited budgets, fostering inclusive community engagement and sustainable development. Eligible projects include environmental assessments, public health initiatives, and job training.

The Patient-Centered Outcomes Research Institute (PCORI) Funding Announcement aims to enhance methods for conducting patient-centered comparative clinical effectiveness research. This initiative seeks to address critical methodological gaps, focusing on improving the use of artificial intelligence in clinical research, study design, data research networks, and ethical protections in patient-centered CER. With a budget of up to $750,000, successful proposals will contribute to the quality and strength of evidence generated in CER studies.

The Patient-Centered Outcomes Research Institute (PCORI) is offering funding up to $750,000 for studies aimed at addressing critical methodological gaps in patient-centered comparative clinical effectiveness research. This initiative focuses on enhancing the quality of evidence in clinical research by prioritizing areas such as artificial intelligence, study design improvements, support for data research networks, and ethical considerations. Successful proposals will contribute to advancing research methodologies and improving patient outcomes.

The Patient-Centered Outcomes Research Institute (PCORI) is funding Cycle 3 to enhance patient-centered comparative clinical effectiveness research (CER). This initiative targets critical methodological gaps, focusing on improving the use of artificial intelligence, study design, data research networks, and ethical protections. By addressing these areas, PCORI aims to strengthen the quality of evidence in CER, thus promoting better outcomes in healthcare decision-making.

The Risk and Protective Factors of Family Health initiative invites research proposals to explore family health and resilience, addressing health disparities in minority communities. Key submission deadlines are set for various dates from February 2025 to February 2027. This program is supported by the National Institutes of Health, highlighting the importance of family well-being as a critical area for advancing health equity. Proposals should focus on interventions that improve family health outcomes.

The ASTS: Veloxis Fellowship in Transplantation Grant offers $42,500 per year for two years to support clinical training in solid organ transplantation. This grant is aimed at current transplant surgery trainees who have completed their surgical residency and are committed to the field. Awardees must attend the ASTS Award Ceremony and complete their fellowship at the same institution for the duration of the award, ensuring a focused and comprehensive training experience.

This funding opportunity aims to address the urgent mental health crisis in the U.S. by promoting research that enhances access to evidence-based practices for youth. It encourages applications focusing on interventions for underserved populations, including those facing housing and food insecurities. Researchers are invited to explore strategies for improving service delivery, overcoming workforce challenges, and integrating care into accessible settings, ultimately striving for equitable mental health services for all youth.